AC Immune (ACIU) Cash from Operations (2015 - 2025)
AC Immune (ACIU) reported Cash from Operations of 20932070.62 for Q4 2025, down 409.02% year-over-year from 6773790.65 in Q4 2024, and up 10.36% on a QoQ basis from 23352045.73 in Q3 2025.
AC Immune (ACIU) has 11 years of Cash from Operations data on file, last reported at 20932070.62 in Q4 2025.
- Quarterly Cash from Operations fell 409.02% year-over-year to 20932070.62 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 85385299.71 (down 217.97% YoY) and the FY2025 annual result came in at 85598939.26, down 213.89% from the prior year.
- Cash from Operations advanced to 20932070.62 in Q4 2025 per ACIU's latest filing, from 23352045.73 in the prior quarter.
- Across five years, Cash from Operations topped out at 80752780.98 in Q2 2024 and bottomed at 25059434.29 in Q1 2022.
- The 5-year median for Cash from Operations is 17904454.47 (2022), against an average of 11448316.5.
- The widest annual swing landed in 2024, when Cash from Operations surged 611.76%; it then sank 1935.27% in 2025.
- Tracing ACIU's Cash from Operations over 5 years: stood at 18821533.9 in 2021, then rose by 6.25% to 17644296.46 in 2022, then dropped by 4.59% to 18454792.73 in 2023, then jumped by 136.7% to 6773790.65 in 2024, then tumbled by 409.02% to 20932070.62 in 2025.
- Per Business Quant, the three latest ACIU Cash from Operations figures stand at 20932070.62 (Q4 2025), 23352045.73 (Q3 2025), and 19570237.49 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.93 Mn |
| Dec 31, 2025 | -20.93 Mn |
| Sep 30, 2025 | -23.35 Mn |
| Sep 30, 2025 | -23.35 Mn |
| Jun 30, 2025 | -19.57 Mn |
| Jun 30, 2025 | -19.57 Mn |
| Mar 31, 2025 | -21.53 Mn |
| Mar 31, 2025 | -21.53 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Jun 30, 2024 | 80.75 Mn |
| Jun 30, 2024 | 80.75 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | -18.45 Mn |
| Dec 31, 2023 | -18.45 Mn |
| Sep 30, 2023 | -15.25 Mn |
| Sep 30, 2023 | -15.25 Mn |
| Jun 30, 2023 | -15.78 Mn |
| Jun 30, 2023 | -15.78 Mn |
| Mar 31, 2023 | -18.16 Mn |
| Mar 31, 2023 | -18.16 Mn |
| Dec 31, 2022 | -17.64 Mn |
| Dec 31, 2022 | -17.64 Mn |
| Sep 30, 2022 | -14.02 Mn |
| Sep 30, 2022 | -14.02 Mn |
| Jun 30, 2022 | -20.23 Mn |
| Jun 30, 2022 | -20.23 Mn |
| Mar 31, 2022 | -25.06 Mn |
| Mar 31, 2022 | -25.06 Mn |
| Dec 31, 2021 | -18.82 Mn |
| Dec 31, 2021 | -18.82 Mn |
| Sep 30, 2021 | -15.79 Mn |
| Sep 30, 2021 | -15.79 Mn |
| Jun 30, 2021 | -17.57 Mn |
| Jun 30, 2021 | -17.57 Mn |
| Mar 31, 2021 | -19.18 Mn |
| Mar 31, 2021 | -19.18 Mn |
| Dec 31, 2020 | -21.12 Mn |
| Dec 31, 2020 | -21.12 Mn |
| Sep 30, 2020 | -16.94 Mn |
| Sep 30, 2020 | -16.94 Mn |
| Jun 30, 2020 | -15.43 Mn |
| Jun 30, 2020 | -15.43 Mn |
| Mar 31, 2020 | -10.01 Mn |
| Mar 31, 2020 | -10.01 Mn |
| Dec 31, 2019 | -12.87 Mn |
| Dec 31, 2019 | -12.87 Mn |
| Sep 30, 2019 | 17.27 Mn |
| Sep 30, 2019 | 17.27 Mn |
| Jun 30, 2019 | -14.99 Mn |
| Jun 30, 2019 | -14.99 Mn |
| Mar 31, 2019 | 66.25 Mn |
| Mar 31, 2019 | 66.25 Mn |
| Dec 31, 2018 | -11.51 Mn |
| Dec 31, 2018 | -11.51 Mn |
| Sep 30, 2018 | -12.04 Mn |
| Sep 30, 2018 | -12.04 Mn |
| Jun 30, 2018 | -7.25 Mn |
| Jun 30, 2018 | -7.25 Mn |
| Mar 31, 2018 | -14.07 Mn |
| Mar 31, 2018 | -14.07 Mn |
| Dec 31, 2017 | 28.82 Bn |
| Dec 31, 2017 | 28.82 Bn |
| Sep 30, 2017 | -29.55 Bn |
| Sep 30, 2017 | -29.55 Bn |
| Jun 30, 2017 | -9.15 Mn |
| Jun 30, 2017 | -9.15 Mn |
| Mar 31, 2017 | -11.84 Mn |
| Mar 31, 2017 | -11.84 Mn |
| Dec 31, 2016 | -7.01 Mn |
| Dec 31, 2016 | -7.01 Mn |
| Sep 30, 2016 | 8.78 Mn |
| Sep 30, 2016 | 8.78 Mn |
| Jun 30, 2016 | 497,798.22 |
| Jun 30, 2016 | 497,798.22 |
| Mar 31, 2016 | -7.74 Mn |
| Mar 31, 2016 | -7.74 Mn |
| Dec 31, 2015 | -5.63 Mn |
| Dec 31, 2015 | -5.63 Mn |